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Background: Familial Mediterranean fever (FMF) is a systemic autoinflammatory disease that causes recurrent attacks of fever,
polyserositis, arthritis or skin eruptions, resulting in pain in the abdomen, muscles, joints and chest. All of these might lead to a
reduction in exercise capacity, muscle strength, physical activity level (PAL) and quality of life (QoL). Therefore, assesment of these
parameters are important. The aim of this study was to assess exercise capacity, muscle strength, PAL, and QoL in patients with FMF as
compared to controls.
Materials and methods: A total of 40 subjects with FMF and 36 healthy control subjects participated in the study. The 6-minute walk
test (6MWT) was used to assess exercise capacity. Muscle strength measurements for shoulder flexors, extensors and abductors, hip
flexors, extensors and abductors, knee flexors and extensors, and ankle dorsiflexors were evaluated by hand-held dynamometer. PAL was
assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF). QoL was investigated by Nottingham Health
Profile (NHP).
Results: Significant differences were found between patients and healthy subjects for 6MWT (p = 0.003), muscle strength of ankle
dorsiflexors (p = 0.001), hip flexors (p = 0.047), extensors (p = 0.003) and abductors (p = 0.004), total scores of IPAQ-SF (p = 0.004),
and pain (p < 0.001), physical mobility (p < 0.001) and energy level (p = 0.026) subscales of NHP. However, there were no significant
differences between groups for the shoulder flexion (p = 0.089), extension (p = 0.440) and abduction (p = 0.232), hand grip strength (p
= 0.160) , and knee flexion (p = 0.744) and extension (p = 0.155) muscle strength and emotional reaction (p = 0.088), sleep (p = 0.070)
and social isolation (p = 0.086) subsets of NHP.
Conclusion: Subjects with FMF demonstrated lower exercise capacity, muscle strength, PAL and QoL than healthy peers. Therefore, it
is important to evaluate and improve these parameters in patients with FMF.
Key words: Exercise capacity, familial Mediterranean fever, muscle strength, physical activity, quality of life

1. Introduction
Familial Mediterranean fever (FMF) is a common systemic
autoinflammatory disease characterized by short-term
recurrent attacks of fever, polyserositis and arthritis
that results in pain in the abdomen, joints, muslces and
chest [1,2]. It has been shown that the attacks are often
associated with high levels of acute phase reactants, and
last in 1 to 4 days [3,4]. In general, patients are symptom
free in between attacks [4].
FMF is a lifelong disease; therefore, patients with
FMF require daily colchicine utilization. However, this
medication might lead to myopathy and decrease the
muscle strength [5]. Furthermore, almost 10% of patients
complain about muscle pain in the lower limb that arises

after physical effort or prolonged standing [6]. Moreover,
arthritis of FMF have an effect on joints during the attack
period. It usually causes pain and swelling of a single and
large joint of the lower limbs. Although this situation lasts
between 1–3 days in most patients, it is rarely prolonged in
some patients. Protracted arthritis can be seen 5% of FMF
patients and mostly affect hips or knees [4]. In some cases,
upper extremity involvement is also seen, yet, it is rare [7].
Chronic process of FMF may give rise to mood
disturbances and disease related complications. The
sypmtoms of rheumatic diseases are thought to cause an
inactive lifestyle [8,9]. As stated in previous studies, physical
inactivity and sedantary life may have detrimental effect
on manifestations of rheumatic diseases by deteriorating
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muscle function, exercise capacity, and eventually quality
of life (QoL) [10,11].
In the literature, it was indicated that young patients
with FMF demonstrated lower exercise capacity, quadriceps
muscle strength [11] and QoL [11,12] than healty controls.
It was also remarked that QoL of adult patients with FMF is
lower than healty controls [13,14]. In a study, it was found
that FMF attacks considerably impair the physical activity
of patients. However, in that study, physical activity levels
of patients were not compared to healthy controls [15].
As mentioned earlier, arthralgia can be observed in
upper extremities of patients with FMF, although not as
often as in the lower limbs. Yet, there is no study in the
literature that examines the upper limb muscles’ strength
and hand grip strength of patients with FMF. Besides, when
the studies were investigated, it was determined that only
quadriceps muscle strength was examined for the lower
extremity [11]. However, only quadriceps muscle do not
reflect the strength of the lower limb muscles. Muscles such
as ankle dorsiflexors, hip flexors, hip abductors, and so on
are also important for gait [16], and these muscles might
affect the physical activity level [17] and aerobic capacity
[18] of patients.
Only one study in the literature evaluated quadriceps
muscle strength and aerobic capacity in children with FMF.
According to the results of this study, it was found that
children with FMF had lower quadriceps muscle strength
and aerobic capacity compared to healthy controls [11].
There is a lack of research in the literature on upper and
lower extremity muscle strength, exercise capacity, and
physical activity level in adults with FMF. It is important
to evaluate lower and upper extremity muscle strength.
Arthritis, which occurs with attacks and sometimes
prolongs, might affect the joints in the lower and upper
extremities. As a result, patients may experience physical
inactivity. Increased physical inactivity might cause a
decrease in aerobic capacity. All of these might lead to
worsening of the QoL in patients with FMF. Therefore, the
above-mentioned parameters should be evaluated. The aim
of this study was to investigate exercise capacity, strength,
physical activity level and QoL of patients with FMF as
compared to healthy controls.
2. Materials and methods
2.1. Study design
The research was designed as a case-control study.
The ethical approval was obtained by the local ethical
committee. All participants were informed about the
study. They signed a written consent, and the research was
conducted in compliance with Declaration of Helsinki.
2.2. Participants
Forty participants who diagnosed with FMF (male/female:
12/28) and fulfilling the Tel Hashomer criteria, presented

to the rheumatology department of the university hospital
for routine control by a rheumatologist and were found
to be in remission by their physician were included in
the study. Patients who were older than 65 years old or
younger than 18 years old, in the attack period during the
evaluation, had any orthopedic problem such as congenital
problems, amputation, etc. in their lower extremities that
prevents them from walking in order to perform 6MWT,
diagnosed with any rheumatic disease in addition to FMF,
diagnosed with hypertension, and who were illiterate were
excluded from the study. Since, the questionnaires used in
the evaluation take into account the last 1 week, patients
who had an attack in the last 2 weeks were also excluded
from the study. The healthy controls were matched by
age and sex with patients with FMF. Healthy controls
were selected randomly. Thirty-six adults, 18 to 65 years
old, with no known medical conditions were included
in the study as control group. The healthy controls were
matched for sex and age. Demographic data containing
age, dominant hand, body mass index (BMI), duration of
the disease and family history were recorded. In addition,
the participants were questioned about whether they have
exercise habits, complain about myalgia in their lower
extremities. Moreover, the number of attacks in the last 3
months, the drug they used and the daily dose of this drug
were also recorded.
2.3. Measures
Exercise capacity: The 6-minute walk test (6MWT)
was used to assess exercise capacity of the participants
since, in general, daily living activities are performed at
submaximal levels of effort. Thus, it was recommended
that submaximal functional tests demonstrate better
reflection of physical ability. Additionally, 6MWT is well
tolerated by patients, easy and has been widely used as an
outcome measure to assess exercise capacity of patients
with chronic disease [19]. Baseline dyspnea, overall
fatigue and leg fatigue questioned according to the Borg
scale and vital signs (heart rate, blood pressure, oxygen
saturation and respiration rate) of participants were
recorded before the 6MWT. Due to the learning effect, as
stated in the guidelines, the participants performed this
test on the 30-m track, 2 times with an interval of 30 min.
Before the tests, participants were given the same verbal
instructions. All information about the test was given to
the participants before starting the test, then, they asked
to walk the maximum distance that they can do without
jogging or running in a 6-min period. They were allowed
to slow down, to stop or to rest if necessary, and continue
to walk as immediate as possible. The researchers kept
the participants informed about the remaining time, and
ensured encouragements after each minute during the
test. After the test was completed and recovery time (1
min after the end of the test), the data recorded before the
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test were reevaluated [20]. The total walking distance was
recorded in meters.
Strength: Hand-held dynamometer (Lafayette Manual
Muscle Tester, Model 01,163, Lafayette Instrument
Company, Lafayette, IN, USA) was used to evaluate muscle
strength of the participants. Shoulder flexor, extensor and
abductor, hip flexor, extensor and abductor, knee flexor
and extensor and ankle dorsiflexor muscles’ strengths
were assessed by the same researcher. Measurement for all
muscles was performed as described in previous studies
[21,22]. Only dominant extremities were evaluated. The
test was repeated 3 times with an interval of 30 s, and the
avarage score was recorded.
Grip strength was evaluated using a hand-held
dynamometer. (Jamar, Sammons Preston, Bolingbrook, IL,
UK). This assessment was conducted with the participant
in an upright position, sitting on a chair with the back
supported, the arm of the participant was in adduction
and the elbow in flexion of 90° [23]. Each assessment was
repeated 3 times for dominant hand. Then, the avarage
score of the 3 repetead measurements was recorded.
Physical activity level: Turkish version of the
International Physical Activity Questionnaire-Short Form
(IPAQ-SF) was used to assess physical activity level of
participants. This questionnaire comprise of 7 questions
asking individuals to remember the physical activity of
the previous week. It inquires about the total of time that
participants spent sitting, walking or doing moderate
(e.g., doubles tennis) or vigorous activities (e.g., digging
aerobics). For IPAQ-SF, physical activities fall into 4
different domains: activities of leisure time, gardening
and domestic activities, work-related activities, and
transportation. As a result of the calculation of total score,
the physical activity level can be divided into 3 groups
as low, medium and high. A higher total score from the
questionnaire indicates greater physical activity [24].
Health related quality of life (HRQoL): The Nottingham
Health Profile (NHP) was used to evaluate HRQoL of
the participants. NHP was developed to assess HRQoL
in different perspectives. It is a general self-evaluation
of subjective status of health in several areas and can be
completed in a short time. It comprises of 2 parts. The
first part of NHP consist of questions that inquires about
currently experienced problems, which are related to
social, psychological and physical functioning associated
with health status. It focuses on 6 dimensions and includes
38 questions, which are related to pain, vital energy, sleep
disorders, physical fitness, emotional reaction and social
isolation. The second part of NHP contains 7 questions
that referred to housework, paid work, social, family and
sexual life, hobbies and interests, and the use of leisure
time. Higher score indicates greater severity of health
problems [25].
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2.4. Statistical analysis
Data analysis were conducted using Statistical Package for
the Social Sciences (SPSS Inc. Version 21; IBM, Raleigh,
NC, ABD) for Windows. Normality distribution of data
was tested by using Shapiro–Wilk test. Descriptive data
were expressed as means ± standart deviation (sd) where
appropriate. To compare two groups, Student t test (age,
sex, BMI (body mass index), dominant hand, exercise
habit, muscle strength, grip strength, 6MWT, IPAQ-SF and
NHP) was utilised. The p values were accepted significant
at <0.05.
3. Results
Forty patients with FMF and 36 healthy individuals were
included in this study. The mean ages of patients with FMF
and healthy control group were 34.97 ± 11.6 years and 30.88
± 8.88 years, respectively. The mean BMI was 25.48 ± 4.77
for the patients and 23.88 ± 3.84 for the healthy subjects.
There were no significant differences between FMF and
the control group with regards to gender (p = 0.959), age
(p = 0.087) and BMI (p = 0.111). Other demographic
characteristics of participants are listed in Table 1.
The mean grip strength value of patients and control
group were 28.16 ± 12.11 and 31.84 ± 10.28, respectively.
There was not any significant difference between 2
groups in terms of grip strength (p = 0.160). Half of the
healthy control group were low, and half were moderately
physically active. Of those with FMF, 29 were low and 11
were moderately physically active. There was a statistically
significant difference between 2 groups in regards to
activity categories of IPAQ (p = 0.044) (Table 2). According
to the results of this study, when muscle strength is taken
into account, the mean muscle strength of hip flexors was
221.31 ± 66.05 in the healthy control group and 192.50 ±
58.49 in the FMF group, the mean muscle strength of the
hip extensors was 241.95 ± 95.82 in the healthy control
group and 184.08 ± 65.11 in FMF group. The mean muscle
strength of the hip abductors was 265.95 ± 78.60 in the
healthy control group and 212.24 ± 76.56 in the FMF
group, the mean muscle strength of ankle dorsiflexors was
251.97 ± 85.08 in the healthy control group and 192.65 ±
63.14 in the FMF group. Considering the mean 6MWT
results, it was 633.61 ± 57.97 in the healthy control group
and 565.65 ± 72.31 in FMF group. Considering the mean
IPAQ (MET) values, it was 911.95 ± 771.21 in the healthy
control group and 463.61 ± 482.69 in FMF group. The rest
of muscle strength measurements’of participants are listed
in Table 2. Significant differences were found between
patients and healthy subjects for muscle strength of ankle
dorsiflexors (p = 0.001), hip flexors (p = 0.047), extensors
(p = 0.003) and abductors (p = 0.004), 6MWT (p = 0.003),
and total scores of IPAQ (p = 0.004). These results indicate
that patients with FMF have lower muscle strength,
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Table 1. Characteristics of the participants.
Characteristic

Control
N = 36

FMF
N = 40

p

Age, years

30.88 ± 8.88

34.97 ± 11.6

0.087

Sex, female/male

27/9

28/12

0.959

BMI, kg/m2

23.88 ± 3.84

25.48 ± 4.77

0.111

Dominant hand, right/left

35/1

39/1

0.941

Disease duration, years

n.a.

10.02 ± 7.26

n.a.

Colchicine dose, mg, median ± SD

n.a.

1.52 ± 0.55

n.a.

Myalgia, yes/no

n.a.

23/17

n.a.

Exercise habit, yes/no

11/25

6/34

0.112

Number of attacks in last 3 months, median (min-max)

n.a.

1.5 (0-7)

n.a.

FMF: familial Mediterranean fever, cm: centimeter, kg: kilogram, m: meter, mg: milligram, n.a.: not applicable
Table 2. Muscle strength, exercise capacity characteristics and physical activity level of participants.
Assessment

Control
N = 36

FMF
N = 40

p

Shoulder flexors, N

173.78 ± 61.18

150.16 ± 58.4

0.089

Shoulder extensors, N

150.23 ± 49.49

140.41 ± 59.56

0.440

Shoulder abductors, N

161.78 ± 49.12

146.61 ± 59.40

0.232

Hip flexors, N

221.31 ± 66.05

192.50 ± 58.49

0.047

Hip extensors, N

241.95 ± 95.82

184.08 ± 65.11

0.003

Hip abductors, N

265.95 ± 78.60

212.24 ± 76.56

0.004

Knee flexors, N

144.36 ± 45.75

140.85 ± 47.37

0.744

Knee extensors, N

221.46 ± 62.54

199.70 ± 68.82

0.155

Ankle dorsiflexors, N

251.97 ± 85.08

192.65 ± 63.14

0.001

Grip strength, N

31.84 ± 10.28

28.16 ± 12.11

0.160

6MWT, meter

633.61 ± 57.97

565.65 ± 72.31

0.003

IPAQ, MET

911.95 ± 771.21

463.61 ± 482.69

0.004

IPAQ, category
Low
Moderate

18
18

29
11

0.044

N: Newton, 6MWT: 6-minute walk test, MET: metabolic equivalent, IPAQ: International Physical
Activity Questionnaire,

exercise capacity and physical activity level than healthy
controls. According to the results of NHP subscales, the
mean results for pain subscale was 6.63 ± 15.46 in the
healthy control group and 32.67 ± 27.34 in FMF group,
the mean results for physical mobility subscale was 3.00 ±
6.12 in the healthy control group and 16.73 ± 14.72 in FMF
group, and the mean results for the energy level subscale
was 23.53 ± 33.60 for the healthy control group and 42.96
± 40.73 for FMF group. The remaining results of subscales

of NHP are listed in Table 3. Significant differences were
found between patients and healthy subjects for pain (p
< 0.001), physical mobility (p < 0.001) and energy level (p
= 0.026) subscales of NHP, which remarks lower QoL of
patients with FMF than healthy controls.
4. Discussion
According to the results of this study, it was found that
hip muscles’ strengths, ankle dorsiflexion muscle strength,
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Table 3. Quality of life characteristics of participants.
Assessment

Control
N = 36

FMF
N = 40

p

NHP Pain

6.63 ± 15.46

32.67 ± 27.34

<0.001

NHP Emotional reactions

11.85 ± 17.50

20.25 ± 24.51

0.088

NHP Sleep

17.57 ± 26.11

19.90 ± 27.08

0.070

NHP Social isolation

6.79 ± 13.78

13.77 ± 20.17

0.086

NHP Physical mobility

3.00 ± 6.12

16.73 ± 14.72

<0.001

NHP Energy level

23.53 ± 33.60

42.96 ± 40.73

0.026

NHP: Nottingham Health Profile.

functional capacity, physical activity level, and QoL were
significantly lower in patients with FMF than healthy
subjects. To the best of our knowledge, this is the first
research investigating the exercise capacity, strength, and
physical activity level in adult patients with FMF.
It is known that chronic diseases give rise to both
psychological and physical symptoms, and these symptoms
lead to difficulties in daily living activities and QoL [26].
Increasing the QoL in individuals with chronic diseases is
one of the most important goals of treatment. HRQoL is
a multidimensional concept, which focuses on subjective
perception of emotional, social, and physical functioning
[27]. Therefore, evaluation of HRQoL is important to
understand the effects of disease on patients’ life. HRQoL
can be assessed easily by patient reported instruments.
Thus, NHP was used in this study to evaluate HRQoL of
adult patients with FMF. As a result of this study, it was
observed that scores of pain, physical mobility, and energy
level sections were significantly lower in patients with FMF
than healthy controls. Prior studies indicated that QoL is
considerably impaired in children and young patients with
FMF than healty subjects [11,12]. Furthermore, the same
results were found in studies examining the QoL of adult
FMF patients [13,14,28]. The fact that the disease progresses
with attacks, the emergence of symptoms during the attack
period, etc. affects the QOL, as seen in other studies, was
an expected result. Our findings regarding HRQoL are
compatible with the previous studies.
As mentioned earlier, musculoskeletal symptoms are
common in patients with FMF. Arthritis, artralgia, and
myalgia might affect mostly hips or knees [4]. Since the
attacks of these patients are painful and physical exertion
causes attacks, patients turn to an inactive lifestyle [15]. This
situation cause limitations in physical performance in daily
living activities. For this reason, patients with FMF might
have more problems in performing daily living activities
due to lower physical activity level and exercise capacity
than healthy individuals. In this study, the mean distance
for 6MWT covered by patients was statistically lower than
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healthy controls. In a previous study, it was found that the
exercise capacity of children patients with FMF was lower
than the healthy control group [11]. Our results regarding
exercise capacity are compatible with the literature. The
reason for this result might be, as stated in Babaoglu et
al.’s study, patients are physically inactive during the attack
period [15]. Moreover, given EULAR (European League
Against Rheumatism) recommendations, patients are
informed by their physicians that physical stress triggers
FMF attacks [29]. All of these result in a decrease in
exercise capacity.
It has been proven in previous studies that the
symptoms seen in rheumatological diseases cause an
inactive lifestyle [30,31]. We thought that the symptoms
of the musculoskeletal system mentioned above, occurring
during the attack period and sometimes prolonged in
patients with FMF would decrease the level of physical
activity by causing an inactive lifestyle as in other
rheumatological diseases. Therefore, the physical activity
level of these patients was evaluated. In this study, physical
activity level of patients with FMF was found lower than
healthy controls. In a study evaluating the physical activity
of patients with FMF, it was determined that the number
of steps of these patients decreased statistically significant
in the attack period compared to the number of steps in
the non-attack period [15]. However, there is no study
comparing the physical activity level of healthy controls
and patients with FMF.
Joint pain is the third most common clinical finding
of FMF after fever and abdominal pain. An articular FMF
attack generally presents as monoarthritis, and it often has
an effect on the large joints of lower limbs. It was indicated
that swelling of joints and presence of joint pain often lead
to decreases in muscle mass and strength in patients with
inflammatory arthritis. Moreover, myalgia is one of the
findings of FMF. It occurs in about 10% of patients and it
frequently affects calf and thigh muscles. Myalgia can be
improved by rest [32]. This, in turn, might lead to physical
inactivity of patients, resulting in decreased muscle strength
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indirectly. Furthermore, in musculoskeletal diseases,
muscle strength can be affected by disease duration, druginduced myopathy, and joint status [8]. Although it is not as
frequent as the lower extremity, it has been reported in the
literature that the musculoskeletal system is also affected
in the upper extremity [7]. For this reason, we investigated
the strength of shoulder, hip, knee and ankle muscles,
which are used in daily living activities. In addition, hand
grip strength was also evaluated. According to the muscle
strength measurement results, a significant difference was
found between healthy individuals and patients with FMF
for the ankle dorsiflexor, hip flexor, extensor and abductor
muscles. Yet, there was no significant difference between
shoulder flexors, extensors and abductors, knee flexors
and extensors, and hand grip strength between healthy
individuals and patients with FMF. Upper limb muscles’
strength and hand grip strength were lower in FMF patients
compared to healthy subjects; however, no statistically
significant difference was found. Our findings regarding
upper extremity muscle strength and hand grip strength
are compatible with prior studies. Muscle strength of hip
muscles, knee flexors and ankle dorsiflexors has not been
evaluated in previous studies. A study evaluating knee
extensors found that young patients with FMF had a lower
knee extensor strength than healthy subjects [11]. Yet,
in our study, although the quadriceps muscle strength of
FMF patients was lower compared to the healthy subjects,
no statistically significant difference was found between
two groups. The previous study was conducted with 100
children with FMF and 55 healthy subjects [11]. The reason

why there was no statistically significant difference in knee
muscle strength in this study might be the lower number of
participants compared to the previously mentioned study.
It has been stated in the literature that all lower extremity
muscles affect walking levels and physical activity level;
however, hip abductor muscles and ankle dorsi flexor
muscles play an important role in walking parameters
[33]. Considering this information, the weakness of the
hip and ankle muscles may explain that the patients with
FMF demonstrate lower physical activity levels and, thus,
exercise capacity compared to healthy individuals.
The lack of correlation analysis for the parameters
evaluated is a limitation of this study. These analyzes are
recommended for future studies.
All in all, patients with FMF demonstrated lower
physical activity level, exercise capacity, QoL, muscle
strength of ankle dorsiflexors, hip flexors, extensors and
abductors than healthy controls. Therefore, evaluation
of these parameters in patients with FMF is of great
importance in terms of elimination of muscle weakness,
increasing physical activity level and aerobic capacity, and
improving the QoL.
Acknowledgement/Disclaimers/Conflict of interest
There is no funding for this study. The authors report no
conflict of interest.
Informed consent
Ethics committee approval was obtained for this study and
all participants signed an informed consent form.

References
1.

Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet
1998; 351 (9103): 659-664. doi: 10.1016/S0140-6736(97)09408-7

2.

Önen F. Familial Mediterranean fever. Rheumatology
International 2006; 26 (6): 489-496. doi: 10.1007/s00296-0050074-3

3.

Küçük A, Gezer IA, Uçar R, Karahan AY. Familial
Mediterranean fever. Acta Medica (Hradec Kralove) 2014; 57
(3): 97-104. doi: 10.14712/18059694.2014.47

4.

Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R. The
musculoskeletal manifestations of familial Mediterranean
fever in children genetically diagnosed with the disease.
Arthritis & Rheumatology 2001; 44 (6): 1416-1419.
doi:
10.1002/1529-0131(200106)44:6<1416::AIDART236>3.0.CO;2-6

5.

6.

Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski M
et al. Colchicine myopathy and neuropathy. New England
Journal of Medicine 1987; 316: 1562-1568. doi: 10.1056/
NEJM198706183162502
Padeh S. Periodic fever syndromes. Pediatric Clinics of North
America 2005; 52 (2): 577-609. doi: 10.1016/j.pcl.2005.01.005

7.

Majeed HA, Barakat M. Familial Mediterranean fever
(recurrent hereditary polyserositis) in children: analysis of 88
cases. European Journal of Pediatrics 1989; 148: 636-641. doi:
10.1007/BF00441519

8.

Gualano B, Sa Pinto AL, Perondi B, Prado DML, Omori C et
al. Evidence for prescribing exercise as treatment in pediatric
rheumatic diseases. Autoimmunity Reviews 2010; 9 (8): 569573. doi: 10.1016/j.autrev.2010.04.001

9.

Gualano B, Pinto AL, Perondi MB, Roschel H, Sallum AME
et al. Therapeutic effects of exercise training in patients
with pediatric rheumatic diseases. Revista Brasileira de
Reumatologia 2011; 51 (5): 490-496

10.

Proctor DN, Melton LJ, Khosla S, Crowson CS, O’Connor MK
et al. Relative influence of physical activity, muscle mass and
strength on bone density. Osteoporosis International 2000;11:
944-952. doi: 10.1007/s001980070033

11.

Alaylı G, Durmuş D, Özkaya O, Şen HE, Nalcacıoğlu H et al.
Functional capacity, strength, and quality of life in children
and youth with familial Mediterranean fever. Pediatric
Physical Therapy 2014; 26 (3): 347-352. doi: 10.1097/
PEP.0000000000000052

1717

TORE et al. / Turk J Med Sci
12.

Makay B, Ünsal E, Arslan N. Quality of life of school-age
children with Familial Mediterranean fever: a preliminary
study. Pediatric Rheumatology 2008; 6 (1): 206. doi:
10.1186/1546-0096-6-S1-P206

23.

Mathiowetz V, Weber K, Volland G, Kashman N. Reliability
and validity of grip and pinch strength evaluations. Journal
of Hand Surgery (American Volume) 1984; 9: 222-226. doi:
10.1016/s0363-5023(84)80146-x

13.

Buskila D, Zaks N, Neumann L, Livneh A, Greenberg S et al.
Quality of life of patients with familial Mediterranean fever.
Clinical and Experimental Rheumatology 1997; 15 (4): 355360

24.

Sağlam M, Arıkan H, Savcı S, İnal-İnce D, Boşnak-Güçlü M et
al. International physical activity questionnaire: reliability and
validity of the Turkish version. Perceptual and Motor Skills
2010;111 (1): 278-284. doi: 10.2466/06.08.PMS.111.4.278-284

14.

Şahin S, Yalçın I, Şenel S, Ataseven H, Uslu AU et al. Assesment
life quality of familial Mediterranean fever patients by short
form-36 and its relationship with disease parameters. European
Review for Medical and Pharmacological Sciences 2013; 17 (7):
958-963

25.

Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The
Nottingham Health Profile: subjective health status and
medical consultations. Social Science and Medicine 1981; 15
(3): 221-229. doi: 10.1016/0271-7123(81)90005-5

26.

15.

Babaoğlu H, Varan Ö, Ataş N, Satış H, Salman R et al. Detection
of Familial Mediterranean Fever attacks by using a connected
activity tracker and assessment of impact of attacks to daily
physical activities: a pilot study. Clinical Rheumatology 2019;
38 (7): 1941-1946. doi: 10.1007/s10067-019-04493-6

McDougall J, Wright V, Schmidt J, Miller L, Lowry K. Applying
the ICF framework to study changes in quality-of-life for youth
with chronic conditions. Developmental Neurorehabilitation
2011; 14 (1): 41-53. doi: 10.3109/17518423.2010.521795

27.

Petersson C, Simeonsson RJ, Enskar K, Huus K. Comparing
children’s self-report instruments for health-related quality
of life using the International Classification of Functioning,
Disability and Health for Children and Youth (ICF-CY).
Health and Quality of Life Outcomes 2013; 11 (1): 75. doi:
10.1186/1477-7525-11-75

16.

Figueroa AM, Yu S. Commentary on “Functional Capacity,
Strength, and Quality of Life in Children and Youth With
Familial Mediterranean Fever”. Pediatric Physical Therapy
2014; 26 (3): 353. doi: 10.1097/PEP.0000000000000054

17.

Loprinzi PD, Loenneke JP, Hamilton DL. Leisure time
sedentary behavior, physical activity and frequency of protein
consumption on lower extremity strength and lean mass.
European Journal of Clinical Nutrition 2017; 71: 1399-1404.
doi: 10.1038/ejcn.2017.101

28.

Değer SM, Özturk MA, Demirağ MD, Aslan S, Göker B et
al. Health-related quality of life and its associations with
mood condition in familial Mediterranean fever patients.
Rheumatology International 2011; 31 (5): 623-628. doi:
10.1007/s00296-009-1334-4

18.

Hairi NN, Cumming RG, Naganathan V, Handelsman DJ, Le
Couteur DG et al. Loss of muscle strength, mass (sarcopenia),
and quality (specific force) and its relationship with functional
limitation and physical disability: the Concord Health and
Ageing in Men Project. Journal of American Geriatrics
Society 2010; 58 (11): 2055-2062. doi: 10.1111/j.15325415.2010.03145.x

29.

Özen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E et al.
EULAR recommendations for the management of familial
Mediterranean fever. Annals of the Rheumatic Diseases 2016;
75 (4): 644-651. doi: 10.1136/annrheumdis-2015-208690

30.

Sokka T, Hakkinen A, Kautiainen H, Maillefert JF, Toloza S et
al. Physical inactivity in patients with rheumatoid arthritis: data
from twenty-one countries in a cross-sectional, international
study. Arthritis & Rheumatology 2008; 59: 42-50. doi: 10.1002/
art.23255

31.

Lee J, Dunlop D, Ehrlich-Jones L, Semanik P, Sog J et al.
Public health impact of risk factors for physical inactivity in
adults with rheumatoid arthritis. Arthritis Care & Research
(Hoboken) 2012; 64: 488-493. doi: 10.1002/acr.21582

32.

Langevitz P, Zemer D, Livneh A, Shemer J, Pras M et
al. Protracted febrile myalgia in patients with familial
Mediterranean fever. Journal of Rheumatology 1994; 21 (9):
1708-1709

33.

Rab GT. Muscle. In: Rose J, Gamble JG (editors). Human
Walking. 2nd ed. Baltimore, MD, USA: Williams & Wilkins;
1994. pp. 101-121

19.

20.

21.

22.

Paap E, van der Net J, Helders PJ, Takken T. Physiologic
response of the Six-Minute Walk Test in children with juvenile
idiopathic arthritis. Arthritis & Rheumatology 2005; 53 (3):
351-356. doi: 10.1002/art.21175
Crapo RO, Enright PL, Zeballos RJ. ATS statement: guidelines
for the six-minute walk test. American Journal of Respiratory
and Critical Care Medicine 2002; 166: 111-117. doi: 10.1164/
ajrccm.166.1.at1102
Andrews AW, Thomas MW, Bohannon RW. Normative values
for isometric muscle force measurements obtained with handheld dynamometers. Physical Therapy 1996; 76 (3): 248-259.
doi: 10.1093/ptj/76.3.248
Bohannon RW. Reference values for extremity muscle strength
obtained by hand-held dynamometry from adults aged 20 to
79 years. Archives of Physical Medicine and Rehabilitation
1997; 78 (1): 26-32. doi: 10.1016/s0003-9993(97)90005-8

1718

